Stocks · Health care · Pharmaceutical Preparations

PepGen Inc.

PEPG Clue Score35
United States Fiscal year ends December CIK 0001835597 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Michelle L Mellion
25 Jul 2024
Chief Medical Officer
Sold after exercise
7,571
$18.06
$136.74K
Michelle L Mellion
24 Jul 2024
Chief Medical Officer
Sold after exercise
201
$18.01
$3.62K
Michelle L Mellion
18 Jul 2024
Chief Medical Officer
Sold after exercise
12,625
$18.20
$229.80K
Michelle L Mellion
16 Jul 2024
Chief Medical Officer
Sold after exercise
5,901
$18.00
$106.25K
Michelle L Mellion
12 Jul 2024
Chief Medical Officer
Sold after exercise
3,288
$18.04
$59.33K
Michelle L Mellion
2 Jul 2024
Chief Medical Officer
Sold after exercise
37
$18.07
$668.59
Michelle L Mellion
1 Jul 2024
Chief Medical Officer
Sold after exercise
875
$18.01
$15.76K
Michelle L Mellion
24 Jun 2024
Chief Medical Officer
Sold after exercise
9,260
$18.19
$168.43K
Michelle L Mellion
12 Jun 2024
Chief Medical Officer
Sold after exercise
1,086
$18.06
$19.61K
Michelle L Mellion
11 Jun 2024
Chief Medical Officer
Sold after exercise
500
$18.04
$9.02K
Michelle L Mellion
6 Jun 2024
SVP, Clinical Development
Sold after exercise
1,411
$18.00
$25.40K
Michelle L Mellion
5 Jun 2024
SVP, Clinical Development
Sold after exercise
7,245
$18.09
$131.06K
James G McArthur
8 Jun 2023
President and CEO
Sold after exercise
2,381
$16.04
$38.19K
James G McArthur
7 Jun 2023
President and CEO
Sold after exercise
8,419
$16.23
$136.62K
James G McArthur
6 Jun 2023
President and CEO
Sold after exercise
18,150
$16.18
$293.66K
James G McArthur
5 Jun 2023
President and CEO
Sold after exercise
500
$16.06
$8.03K
James G McArthur
2 Jun 2023
President and CEO
Sold after exercise
1,800
$16.04
$28.86K
Jaya Goyal
24 Mar 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
392
$20.00
$7.84K
Jaya Goyal
8 Feb 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
644
$17.00
$10.95K
Jaya Goyal
7 Feb 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
3,679
$17.18
$63.21K
Jaya Goyal
6 Feb 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
1,677
$17.04
$28.57K

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 21
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 9,848,749
History held since 10 May 2022